Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

被引：0
作者：
Rossana Tallerico
Costanza M Cristiani
Mariaelena Capone
Gabriele Madonna
Domenico Mallardo
Ester Simeone
Andrea Dominijanni
Antonio M Grimaldi
Francesco Colucci
Paolo A Ascierto
Ennio Carbone
机构：
[1] University "Magna Graecia" of Catanzaro,Tumorimmunology and Immunopathology Laboratory, Department of Experimental and Clinic Medicine
[2] Istituto Nazionale Tumori Fondazione "G. Pascale",Melanoma. CancerImmunotherapy and Innovative Therapy Unit
[3] Immunohaematological Transfusion Medicine Centre “Pugliese-Ciaccio” Hospital of Catanzaro,Department of Obstetrics and Gynaecology
[4] University of Cambridge Clinical School,Department of Microbiology Cell and Tumorbiology (MTC)
[5] Karolinska Institutet,undefined
来源：
Journal of Translational Medicine | / 13卷 / Suppl 1期
关键词：
Melanoma; Metastatic Melanoma; Melanoma Patient; Ipilimumab; Cell Immune Response;
D O I：
10.1186/1479-5876-13-S1-O8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Morphomics Predicts Response to Ipilimumab in Patients With Stage IV Melanoma
    Sabel, Michael S.
    Lee, Jay
    Wang, Anran
    Lao, Christopher
    Holcombe, Sven
    Wang, Stewart
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 112 (04) : 333 - 337
  • [32] Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab
    Tirumani, Sree Harsha
    Ramaiya, Nikhil H.
    Keraliya, Abhishek
    Bailey, Nancy D.
    Ott, Patrick A.
    Hodi, F. Stephen
    Nishino, Mizuki
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10) : 1185 - 1192
  • [33] PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab
    Madonna, Gabriele
    Ballesteros-Merino, Carmen
    Feng, Zipei
    Bifulco, Carlo
    Capone, Mariaelena
    Giannarelli, Diana
    Mallardo, Domenico
    Simeone, Ester
    Grimaldi, Antonio M.
    Caraco, Corrado
    Botti, Gerardo
    Fox, Bernard A.
    Ascierto, Paolo A.
    ONCOIMMUNOLOGY, 2018, 7 (12):
  • [34] Identifying the Optimal Fractionation Schedules for Improved Response Rates and Survival in Patients with Metastatic Melanoma Treated with Ipilimumab and Radiotherapy
    Liu, Jason
    Xu, Cong
    Zhu, Junjia
    Sivik, Jeffrey
    Drabick, Joseph J.
    Mackley, Heath B.
    CURRENT CANCER THERAPY REVIEWS, 2020, 16 (01) : 78 - 85
  • [35] Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab
    Lucia Brilli
    Riccardo Danielli
    Cristina Ciuoli
    Luana Calabrò
    Anna Maria Di Giacomo
    Alfonso Cerase
    Patrizia Paffetti
    Fausta Sestini
    Brunetta Porcelli
    Michele Maio
    Furio Pacini
    Endocrine, 2017, 58 : 535 - 541
  • [36] Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
    Christiane Meyer
    Laurène Cagnon
    Carla M. Costa-Nunes
    Petra Baumgaertner
    Nicole Montandon
    Loredana Leyvraz
    Olivier Michielin
    Emanuela Romano
    Daniel E. Speiser
    Cancer Immunology, Immunotherapy, 2014, 63 : 247 - 257
  • [37] Association between immune-related adverse events and prognosis in patients treated with immune checkpoint inhibitors in melanoma: A surrogacy analysis
    Euvrard, Romain
    Robert, Marie
    Mainbourg, Sabine
    Dalle, Stephane
    Lega, Jean-Christophe
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (02) : 369 - 379
  • [38] Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Chapman, Paul B.
    Jayaprakasam, Vetri Sudar
    Panageas, Katherine S.
    Callahan, Margaret
    Postow, Michael A.
    Shoushtari, Alexander N.
    Wolchok, Jedd D.
    Warner, Allison Betof
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [39] Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab
    Brilli, Lucia
    Danielli, Riccardo
    Ciuoli, Cristina
    Calabro, Luana
    Di Giacomo, Anna Maria
    Cerase, Alfonso
    Paffetti, Patrizia
    Sestini, Fausta
    Porcelli, Brunetta
    Maio, Michele
    Pacini, Furio
    ENDOCRINE, 2017, 58 (03) : 535 - 541
  • [40] HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab
    Ladanyi, Andrea
    Hegyi, Barbara
    Balatoni, Timea
    Liszkay, Gabriella
    Rohregger, Raphael
    Waldnig, Christoph
    Dudas, Jozsef
    Ferrone, Soldano
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
12345